Could an allergy drug protect kidneys in diabetes?
NCT ID NCT05638880
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether levocetirizine, an allergy medication, can reduce protein leakage in the urine of people with diabetic kidney disease. The trial enrolled 60 adults aged 40-65 with type 2 diabetes and early kidney damage. Researchers measured changes in albuminuria to see if the drug could help control kidney disease progression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC NEPHROPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mansoura University
Al Mansurah, 315511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One infusion, two targets: a uric-acid-lowering drug takes aim at heart and kidney disease in youth-onset diabetes
- Kidney clues may predict eye swelling after cataract surgery in diabetes patients
- Scientists probe kidney cell metabolism to unlock secrets of ANCA vasculitis
- New study probes why kidney disease still strikes in type 1 diabetes
- Lotus seed supplement shows promise for diabetic nerve pain
- New drug aims to slow kidney damage in diabetes and rare diseases